Recent Headlines
Introducing EDI’s COVID-19 Nucleocapsid IgG Quantitative ELISA Kit
The EDI™ COVID-19 Nucleocapsid IgG Quantitative ELISA Kit is designed, developed & produced for the quantitative measurement of human anti-COVID-19 (anti-SARS-CoV-2) IgG antibody in serum. The test uses a series of calibrators & controls in order to determine a standard curve, which allows for specific, concentration-based results of patient samples, giving researchers & healthcare providers access to quantitative patient data in order to better understand a patient's current disease stage. - October 14, 2020 - Epitope Diagnostics, Inc.
ReproTech, Ltd. Celebrates 30 Years in Reproductive Cryostorage
ReproTech, Ltd. is celebrating 30 years as the first company dedicated solely to long-term reproductive tissue storage. Over three decades, ReproTech has expanded from one facility in St. Paul, MN to four regional locations in the United States including Fort Lauderdale, FL; Reno, NV; and... - October 14, 2020 - ReproTech, LLC
Veralize Device Team Named Semi-Finalist for XPRIZE Rapid COVID-19 Testing
Team made up of 12-15 Molecular Diagnostics, African Biosciences Ltd. and Ahmadu Bello University has been selected as semi-finalist in the XPRIZE Rapid COVID-19 Testing competition. The patented rapid response diagnostic device designed by 12-15 Molecular Diagnostics can detect COVID-19 using saliva samples. By algorithmically analyzing the results with the 12-15 Molecular Diagnostics machine learning system, the test can provide 95% accuracy and early detection, even when there are no symptom - October 13, 2020 - African Biosciences Inc.
Cayman Receives SBIR Grant for Alzheimer’s Research
The National Institute on Aging (NIA) has awarded Cayman Chemical with a Phase II Small Business Innovation Research (SBIR) grant to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies. - October 10, 2020 - Cayman Chemical Company
Legionnaires’ Disease Cases Lead to Legionella Water Testing
Hyperion Offers Testing to Identify If Legionella Bacteria Are Growing in a Building’s Water System. - October 03, 2020 - Hyperion Biotechnology, Inc.
Joint Venture Announcement of ECLEVAR and QUINTEN forming ECLEVAR MedTech
ECLEVAR and QUINTEN announced today the formation of the joint venture ECLEVAR MedTech, a medical device contract research organization (CRO) specializing in regulatory compliance and real world evidence post-market solutions. Driven by its innovative data science and machine learning... - October 01, 2020 - ECLEVAR MedTech
Hemanext to Present New Red Blood Cell Research Data at AABB 2020
Four abstracts add to the growing body of evidence supporting hypoxic storage of RBCs. - September 29, 2020 - Hemanext
Dr. Michael Epitropoulos' Position of Chief Scientific Officer at HAPInss Brands LLC
In the newly formed position of Chief Scientific Officer, Dr. Epitropoulos will lead evidenced-based research efforts across the entire HAPInss Brands portfolio of products. - September 23, 2020 - AmpLIFEi International
Ampersand Capital Partners Acquires American Laboratory Products Company
American Laboratory Products Company, Ltd. (ALPCO), a specialty in vitro diagnostics company, today announced the majority recapitalization of the company by Ampersand Capital Partners. Ampersand’s investment will be used to support ALPCO’s worldwide growth initiatives, including the... - September 21, 2020 - ALPCO
Testing is the Only Way to Confirm Water is Not Contaminated with Legionella Bacteria
Hyperion Biotechnology is offering complimentary Legionella water testing to local schools in San Antonio, Texas. - September 17, 2020 - Hyperion Biotechnology, Inc.
Study Points to a New Unexplored Therapeutic Target for C9ORF72-mediated ALS
A novel discovery from scientists at the ALS Therapy Development Institute (ALS TDI) is the first to indicate that asymmetric di-methylation of arginine could be a promising target for ALS therapies. - September 09, 2020 - ALS Therapy Development Institute
Paras Biopharmaceuticals Finland Oy Joins PSL Alliance and Its Global Membership to Promote Worldwide Reach Out for Paras’ Bioprocess Enzymes
Paras Biopharmaceuticals Finland Oy (Paras Biopharma) is pleased to announce that it is now a member of the Pivotal Scientific Limited (PSL) Alliance, a network of companies operating within the biotechnology market. As part of the Company’s portfolio of microbial products, technologies and... - September 08, 2020 - Paras Biopharmaceuticals Finland Oy
Zifo RnD Solutions Partners with Aurigene Discovery Technologies for a Phase III Oncology Trial
Zifo RnD Solutions will be the Data Management Service provider for Aurigene Discovery Technologies’ large data driven Phase III oncology trial. - September 06, 2020 - Zifo
St. John’s to Host Virtual Dribble for the Cure on Sept. 26
Red Storm men’s and women’s basketball teams to support Pediatric Cancer Research Foundation. - September 05, 2020 - Pediatric Cancer Research Foundation
New eClinical Platform Strategic Analysis & Competitive Landscape Report
Survey Quantifies eClinical Platform Use and Satisfaction and Identifies Dramatic Perceptual Changes - August 26, 2020 - Life Science Strategy Group, LLC
AmpLIFEi International(TM) Launches "Travopoly" the Premier Member-Only Booking Engine for the Benefit of VIP Members
Robert Oblon Fulfills Promise to AmpLIFEi(TM) VIP members adding the first VIP Lifestyle service - Travopoly.com. - August 26, 2020 - AmpLIFEi International
Grants Available for Undergraduate Students Seeking Research Experience
Cayman Biomedical Research Institute (CABRI) is now accepting applications from undergraduate students who have been offered an unpaid laboratory research position under an accredited principal investigator. Applications will be accepted until September 20, 2020, for awards to be distributed by November 2, 2020. Grants range from $2,000 - $5,000 and may be awarded as individual or group grants. - August 19, 2020 - Cayman Chemical Company
Cayman and GenScript Partner to Offer Neoantigen Profiling and Synthesis Expertise
Cayman and GenScript have come together to create a complete package of neoantigen discovery services. Through combined efforts, MHC-associated peptides are identified and verified as immunogenic to guide peptide synthesis for vaccine development. “Cayman provides a complete workflow enabling... - August 15, 2020 - Cayman Chemical Company
Harmful Bacteria May be Growing in a Building’s Water During COVID-19 Shutdowns
Legionella Water Testing Kits can help Businesses Reopen Safely. Hyperion Biotechnology now provides everything building owners need to collect samples for laboratory analysis to determine if Legionella bacteria are present. - August 15, 2020 - Hyperion Biotechnology, Inc.
UCLA and the Pediatric Cancer Research Foundation (PCRF) Kick Off Annual “Dribble for the Cure” with Urgent Call for Public to Help Save Lives of Children with Cancer
An annual event that raises money for children's cancer research is going virtual. - August 12, 2020 - Pediatric Cancer Research Foundation
Help for Hotels as They Reopen - Hyperion Biotechnology Offers Legionella Water Testing
Hotel owners can test water systems to ensure guests’ safety from exposure to Legionella, a bacteria that can cause Legionnaires’ disease when spread through mist from a hotel’s water system. - August 07, 2020 - Hyperion Biotechnology, Inc.
Amplifei International Given Approval to Market HAPInss Brands' New “Hemplifei” CBD Products
Through its exclusive marketing agreement, Amplifei will now offer The Hemplifei™ products with an advanced breakthrough in Endocannabinoid Nutrition (ECN). - August 06, 2020 - AmpLIFEi International
Los Angeles-Area Clinic to Offer Free Rapid and Accurate COVID-19 Testing to LAPD and LASD Officers
Near-immediate testing results will give frontline law enforcement officers peace of mind as they both work within the community and return safely to their families. - July 29, 2020 - Thrive Medical
Scientists at AbboMax, Inc. Created a TBNK Panel of Monoclonal Antibodies to Study SARS-CoV-2
Understanding of a host immune response to SARS-CoV-2 is extremely important. It was previously shown that the immune system of patients infected by SARS-CoV-2 is severely impaired. In order to better recognize how immune response is orchestrated, the TBNK (B-Cell, T-Cell, and natural killer cells) panel of antibodies created by AbboMax, Inc. can be employed. - July 22, 2020 - AbboMax, Inc.
Hyperion Biotechnology's Legionella Water Testing Services Can Help Businesses Reopen Safely
Coronavirus is not the only concern for business owners as they reopen. Another threat to health safety is water-borne bacteria called Legionella. - July 17, 2020 - Hyperion Biotechnology, Inc.
Crytur Opens a US Branch
CRYTUR spol s.r.o. announces the opening of a US branch in Boston, MA to provide enhanced support to a rapidly expanding field of North American customers. The US company, Crytur USA, will offer the same high quality products, services and technical support as their customers came to expect from... - July 11, 2020 - Crytur USA
GI Associates of St. Augustine Joins Borland Groover
Merger expands Borland Groover's gastrointestinal health capabilities and presence in Northeast Florida. - July 11, 2020 - Borland Groover
Robert Oblon, a World Renown Thought Leader in the Conversation Between Physical Health and Mental Happiness, Launches HAPInss Brands Nutritional Science Systems
AmpLifei International, through its eCommerce Platform, is the exclusive marketing and distribution partner of HAPInss Brands exclusive and proprietary line of products. - July 10, 2020 - AmpLIFEi International
40 Women Researchers Receive $40,000 in Grants from Cayman and CABRI
Each year during Women’s History Month, Cayman provides travel grants to help women researchers attend conferences to benefit from and contribute to the larger scientific community. This year, because the COVID-19 pandemic caused most conferences to cancel or postpone and many academic labs to close, Cayman introduced a new program to help support women in research. A record high of forty women will benefit from Cayman’s Women in Research program this year. - July 01, 2020 - Cayman Chemical Company
On June 25, "How I Brewed This: Craft Brewer Series” to Feature Two Big Names in the Washington State Brewing Scene
The ALS Therapy Development Institute (ALS TDI) is excited to announce that on Thursday, June 25, they will be hosting the second episode of their new “How I Brewed This: Craft Brewer Series,” featuring Kevin Smith of Bale Breaker Brewing Company and Mike Smith of B.T. Loftus... - June 20, 2020 - ALS Therapy Development Institute
Thalassaemia International Federation and Hemanext® Inc. Announce New Strategic Alliance
Organizations create partnership to support the needs of people living with hemoglobin disorders. - June 11, 2020 - Hemanext
Bio Bench is Cooperating with Helixar Biosciences for the Europe and US Market
Bio Bench has started a partnership with Helixar Biosciences to support its Europe and North America market development. - June 09, 2020 - Bio Bench
Zeteo Biomedical Introduces ZEOx1 AquilaMD™ Ophthalmic Drug Delivery System
Zeteo’s patient-centric ophthalmic delivery systems are designed for precise, self-administration of preservative free drugs and biopharmaceuticals. - June 01, 2020 - Zeteo Biomedical LLC
Kaycha Labs Appoints New Chief Marketing Officer to Support Rapid Growth
Kaycha Labs, LLC, the nationwide leader in cannabis and hemp testing, announced today the appointment of Andrew Varga as Chief Marketing Officer. Mr. Varga, a marketing veteran of over 30 years has led marketing initiatives for companies such as Brown Forman Corporation, Papa John’s Pizza and... - May 30, 2020 - Kaycha Labs
Experimentica Ltd. Announces the Successful Acquisition of the Ophthalmic Contract Research Division from Ophthy-DS, Inc.
Experimentica Ltd., a leader in preclinical ophthalmic drug discovery services, announces the successful acquisition of the contract research division from Ophthy-DS, Inc., a Michigan-based preclinical contract research organization (CRO) specializing in non-regulated drug discovery services and medical device testing for ophthalmic indications. - May 22, 2020 - Experimentica Ltd
Zeteo Biomedical Receives NIH Award to Develop a Universal Nasal Flu Vaccine in Collaboration with the Iowa State University Nanovaccine Institute
Vaccines that can be quickly manufactured, deployed and self-administered at global scale volumes is crucial to protect global populations against pandemic virus threats. - May 20, 2020 - Zeteo Biomedical LLC
Kaycha Labs Named First Designated Laboratory for Florida’s Hemp Program
Florida Department of Agriculture and Consumer Services Approves Kaycha Labs for their USDA Approved Hemp Program - May 20, 2020 - Kaycha Labs
Zeteo Biomedical Introduces ZEOx1 Orion(TM) Nasal Vaccine and Drug Delivery Systems
Zeteo’s patient-centric delivery systems are designed for quick manufacturing to facilitate rapid deployment of drugs and vaccines to global populations. - May 14, 2020 - Zeteo Biomedical LLC
Minus K Technology Releases Its New CT-2 Ultra-Thin, Low-Frequency Passive Vibration Isolator
Minus K's New Ultra-Thin CT-2 Negative-Stiffness Passive Vibration Isolation Platform at Just 2-1/2 Inches in height Isolates Vibrations as Low as 1 Hertz Without the Need for Air or Electricity. - May 07, 2020 - Minus K Technology Inc.
Fast Track MHRA Approval for Vicore Pharma’s COVID-19 Clinical Trial Received in Record Time
Orphan Reach today announced that regulatory approval has been obtained for Vicore Pharma’s Phase II clinical trial with VP01 (C21) in patients with COVID-19, SARS CoV-2 infection. - May 04, 2020 - Orphan Reach
ALS TDI Hosts “Gamers vs. ALS” Virtual Livestream Event to Benefit Critical ALS Research
Gamers can join the livestream video game event on Tiltify, May 3-9, to raise funds for cutting-edge ALS research at the ALS Therapy Development Institute. - May 03, 2020 - ALS Therapy Development Institute
Neurology Associates Offers Video Appointments Throughout Arizona, Out of State
Relaxed Regulations Amid COVID-19 Make Extended Reach Possible - May 02, 2020 - Neurology Associates
New COVID-19 Impact on Biopharmaceutical Industry & CRO Outsourcing Report
Survey Quantifies Current and Expected impact of COVID-19 on Clinical Development and CRO Outsourcing - April 30, 2020 - Life Science Strategy Group, LLC
My-State Trek Virtual Event Provides New Opportunity to Support ALS Research While Social Distancing
Virtual event provides opportunities to get active at home and raise funds for cutting-edge ALS research at the ALS Therapy Development Institute (ALS TDI). - April 29, 2020 - ALS Therapy Development Institute
New Digital App Set to Transform the Landscape of Contact Tracing Practices
In the wake of the COVID-19 epidemic, UK company, Vestigo has launched a new website to promote its efforts to develop a digital tracing app called Dot2Dot and test the prototype within the next few weeks. Dot2Dot will digitise the manual contact tracing procedures utilised by health... - April 17, 2020 - Vestigo
Marlena Holter Named ALPCO’s Winter 2020 Diabetes Research Travel Grant Recipient
ALPCO's Winter 2020 Diabetes Research Travel Grant has been awarded to Marlena Holter, a DVM/PhD candidate from Cornell University’s College of Veterinary Medicine. Ms. Holter’s novel research focuses on GLP-1 regulated glucose regulation following vertical sleeve gastrectomy surgery to define the mechanisms underlying type 2 diabetes remission and metabolic improvement following bariatric surgery. - April 14, 2020 - ALPCO
HealthWare Systems Earns Better Business Bureau Accreditation
HealthWare Systems has earned its Better Business Bureau Accreditation. The revenue cycle management company is now a BBB Accredited Business. - March 20, 2020 - HealthWare Systems
Rare Diseases Research Funded by $220,000 in Grants from CABRI
In its ongoing commitment to funding research for new treatments for rare diseases, Cayman Biomedical Research Institute (CABRI) has announced its principle investigator and undergraduate awardees for the 2020 academic year. “We are excited to support these scientists actively researching... - March 12, 2020 - Cayman Chemical Company
Epitope Diagnostics Has Proudly Introduced Immunoassay Kits Exclusively for the Qualitative Detection of COVID-19
The EDI™ Novel Coronavirus COVID-19 IgG ELISA Kit and EDI™ Novel Coronavirus COVID-19 IgM ELISA Kits. With proven results from clinical testing in China, Epitope Diagnostics, Inc. is eager to cooperate and collaborate to combat the current COVID-19 situation. - March 06, 2020 - Epitope Diagnostics, Inc.
Clinical Guidelines for Physical Therapy in Huntington Disease
HSG Announces Publication of Clinical Guidelines for Physical Therapy in Huntington Disease - February 27, 2020 - Huntington Study Group